Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:1255-1265
Published online before print September 14, 2009, doi: 10.1161/CIRCULATIONAHA.109.873695
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow All Versions of this Article:
120/13/1255    most recent
CIRCULATIONAHA.109.873695v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hirahashi, J.
Right arrow Articles by Mayadas, T. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirahashi, J.
Right arrow Articles by Mayadas, T. N.
Related Collections
Right arrow Animal models of human disease
Right arrow Other Vascular biology
Right arrowRelated Article

(Circulation. 2009;120:1255-1265.)
© 2009 American Heart Association, Inc.


Vascular Medicine

Mac-1 (CD11b/CD18) Links Inflammation and Thrombosis After Glomerular Injury

Junichi Hirahashi, MD, PhD; Keiichi Hishikawa, MD, PhD; Shinya Kaname, MD, PhD; Naotake Tsuboi, MD, PhD; Yunmei Wang, PhD; Daniel I. Simon, MD; George Stavrakis, MS; Tatsuo Shimosawa, MD, PhD; Ling Xiao, MD; Yutaka Nagahama, MS; Kazuo Suzuki, PhD; Toshiro Fujita, MD, PhD; Tanya N. Mayadas, PhD

From the Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan (J.H., K.H., S.K., T.S., T.F.); Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass (J.H., N.T., G.S., L.X., T.N.M.); Department of Medicine, Case Cardiovascular Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Y.W., D.I.S.); In Vitro Diagnostics Department, R&D and Business Development Segment, Mitsubishi Chemical Medicine Corporation, Tokyo, Japan (Y.N.); and Inflammation Program, Department of Immunology, Chiba University Graduate School of Medicine, Chiba, Japan (K.S.).

Correspondence to Tanya N. Mayadas, PhD, Brigham and Women’s Hospital, Department of Pathology, 77 Avenue Louis Pasteur, NRB752O, Boston, MA 02115. E-mail tmayadas{at}rics.bwh.harvard.edu

Received March 21, 2008; accepted July 14, 2009.

Background— Inflammation and thrombosis coexist in several disorders. Although it is recognized that leukocytes may induce a procoagulant state at sites of inflammation, the critical molecular determinants of this process remain largely unknown.

Methods and Results— To examine mechanisms of inflammation-induced thrombosis, we developed a murine model of thrombotic glomerulonephritis (TGN), a known cause of acute renal failure in patients. This model, induced by lipopolysaccharide and antibody to the glomerular basement membrane, led to rapid glomerular neutrophil recruitment, thrombotic glomerular lesions with endothelial cell injury, and renal dysfunction. In mice immunodepleted of neutrophils or lacking the leukocyte-specific integrin Mac-1, neutrophil recruitment, endothelial injury, glomerular thrombosis, and acute renal failure were markedly attenuated despite the robust generation of renal cytokines. Neutrophil elastase is a likely effector of Mac-1 because its activity was reduced in Mac-1–deficient mice and the phenotype in mice deficient in Mac-1 or neutrophil elastase was similar. Platelets accumulated in glomerular capillaries within 4 hours of TGN before evidence of thrombosis. Platelet immunodepletion before TGN markedly exacerbated hematuria (hemorrhage), inflammation, and injury, whereas thrombocytopenic Mac-1–deficient mice remained resistant to disease, indicating that initial glomerular platelet deposition protects the vessel wall from neutrophil-mediated sequelae. The subsequent thrombosis relied on the interaction of Mac-1 on recruited neutrophils with glycoprotein Ib{alpha} on platelets as antibody-mediated disruption of this interaction attenuated TGN without affecting renal neutrophil accumulation.

Conclusions— These observations establish Mac-1 on neutrophils as a critical molecular link between inflammation and thrombosis and suggest it as an attractive target for antithrombotic therapy.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 1165-1167. [Extract] [Full Text]